NCT04288596View on ClinicalTrials.gov

Canadian Adult Congenital Heart Disease Intervention Registry

Not yet recruitingOBSERVATIONAL
Enrollment

9,000

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

April 1, 2030

Study Completion Date

April 1, 2030

Conditions
Atrial Septal DefectPatent Foramen OvaleTetralogy of FallotFontanCoarctation of AortaTransposition of Great VesselsPercutaneous Pulmonary Valve Implantation
Interventions
OTHER

Participants undergoing ACHD intervention

Participants will receive standard of care for their ACHD intervention.

Trial Locations (1)

M5G 2C4

Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT04288596 - Canadian Adult Congenital Heart Disease Intervention Registry | Biotech Hunter | Biotech Hunter